塞拉万斯生物制药 TBPH
$0.00 +$0.00 (0.00%)
休市 · Oct 24, 12:40 am ET
开盘$0.00
昨收$0.00
当日区间$0.00 – $0.00
成交量0.00
市值$884.18M
市盈率（TTM）16.4
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例93.3%-0.20 个百分点，较上季度
持仓机构数218+0 ，较上季度
内部人近期交易17次买入 / 33次卖出净卖出
空头持仓比例3.25% 占流通股回补天数 4.5 · 截至 15 Sep 2026
卖空成交量占比19.8%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$3.16M（4个净流入日，16个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有52.7%的流通股。
最大股东
按投资者类型
过去6次双周报告中（30 Jun 2026至15 Sep 2026），空头持仓占流通股比例已从8.73%降至3.25%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Putnam Fiduciary Trust Company | Private Company | 2026/Q3 | +39,288 | 0.1% |
| Mackenzie Financial Corporation | Mutual Fund | 2026/Q3 | +737,166 | 1.9% |
| Citadel Advisors LLC | Hedge Fund | 2026/Q3 | +420,577 | 1.0% |
| Glazer Capital, LLC | Hedge Fund | 2026/Q3 | +301,834 | 0.6% |
| BlackRock | Mutual Fund | 2026/Q3 | +266,197 | 8.8% |
| D. E. Shaw & Co., L.P. | Hedge Fund | 2026/Q3 | +231,348 | 2.3% |
| Morgan Stanley | Public Company | 2026/Q3 | +158,333 | 1.1% |
| Qube Research & Technologies Ltd | Mutual Fund | 2026/Q3 | +140,340 | 0.8% |
| WEDGE Capital Management LLP | Mutual Fund | 2026/Q3 | +128,845 | 0.2% |
| Millennium Management LLC | Hedge Fund | 2026/Q3 | +115,403 | 0.2% |
| Schonfeld Strategic Advisors LLC | Hedge Fund | 2026/Q3 | +108,879 | 0.2% |
| JPMorgan Chase & Co. | Public Company | 2026/Q3 | +82,955 | 0.3% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +59,436 | 2.0% |
| Sierra Summit Advisors LLC | Family Office/Trust | 2026/Q3 | +59,096 | 0.1% |
| Segall Bryant & Hamill, LLC | Mutual Fund | 2026/Q3 | +56,052 | 0.1% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 14 Sep 2026 | Rhonda Farnum | Chief Business Officer and Senior VP of Commercial & Medical Affairs | Automatic Disposition | -13,314 | $17.03 | 213,476 |
| 19 Aug 2026 | Rick Winningham | Chairperson & CEO | Sale to Issuer | -20,034 | $16.95 | 1,726,989 |
| 19 Aug 2026 | Brett Grimaud | Senior Vice President | Sale to Issuer | -7,952 | $16.95 | 355,168 |
| 19 Aug 2026 | Rhonda Farnum | Chief Business Officer and Senior VP of Commercial & Medical Affairs | Sale to Issuer | -5,667 | $16.95 | 226,790 |
| 19 Aug 2026 | Aziz Sawaf | Senior Vice President | Sale to Issuer | -8,112 | $16.95 | 336,841 |
| 19 Aug 2026 | Aine Miller | VP of Regulatory, Quality, Clinical Safety & Pharmacovigilance and Head of Ireland Office | Sale to Issuer | -6,258 | $16.95 | 189,826 |
| 6 Jul 2026 | Madison Avenue Partners, LP | Open Market Disposition | -6,964 | $17.17 | 9,167,489 | |
| 30 Jun 2026 | Madison Avenue Partners, LP | Open Market Disposition | -336,697 | $17.23 | 9,174,453 | |
| 18 Jun 2026 | Aine Miller | VP of Regulatory, Quality, Clinical Safety & Pharmacovigilance and Head of Ireland Office | Other Acquisition | +18,750 | – | 196,084 |
| 14 Jun 2026 | Rhonda Farnum | Chief Business Officer and Senior VP of Commercial & Medical Affairs | Automatic Disposition | -13,314 | $16.39 | 232,457 |
| 11 Jun 2026 | Deepika Pakianathan | Independent Director | Other Acquisition | +6,009 | – | 64,074 |
| 11 Jun 2026 | Deepika Pakianathan | Independent Director | Other Derivative Acquisition | +13,398 | $16.64 | 13,398 |
| 11 Jun 2026 | Dean Mitchell | Lead Independent Director | Other Acquisition | +6,009 | – | 97,213 |
| 11 Jun 2026 | Dean Mitchell | Lead Independent Director | Other Derivative Acquisition | +13,398 | $16.64 | 13,398 |
| 11 Jun 2026 | Donal O'Connor | Independent Director | Other Acquisition | +6,009 | – | 80,213 |
| 11 Jun 2026 | Donal O'Connor | Independent Director | Other Derivative Acquisition | +13,398 | $16.64 | 13,398 |
| 11 Jun 2026 | Susannah Gray | Independent Director | Other Acquisition | +6,009 | – | 48,146 |
| 11 Jun 2026 | Susannah Gray | Independent Director | Other Derivative Acquisition | +13,398 | $16.64 | 13,398 |
| 11 Jun 2026 | Laurie Smaldone Alsup | Independent Director | Other Acquisition | +6,009 | – | 80,989 |
| 11 Jun 2026 | Laurie Smaldone Alsup | Independent Director | Other Derivative Acquisition | +13,398 | $16.64 | 13,398 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Sep 2026 | 1,686,673 | 3.2% | 4.5 |
| 31 Aug 2026 | 1,618,508 | 3.1% | 4.5 |
| 14 Aug 2026 | 1,714,947 | 3.3% | 2.5 |
| 31 Jul 2026 | 4,168,511 | 8.0% | 7.6 |
| 15 Jul 2026 | 4,306,471 | 8.3% | 5.3 |
| 30 Jun 2026 | 4,502,718 | 8.7% | 4.2 |
暂无评论——快来第一个聊聊 TBPH。